Investment
Features
FeesSafety
Academy
More
Pluang+

Zefiro Methane posts 31% revenue growth in fiscal 2026, narrows net loss by 67.5%, and wins major government contracts.

Company Fundamentals
28 Sep 2026
Newsfile Corp
View Source
Bullish
Zefiro Methane posts 31% revenue growth in fiscal 2026, narrows net loss by 67.5%, and wins major government contracts.

Zefiro Methane Corp. reported a 31.1% revenue increase to $42.5 million and a 66% rise in gross profit for fiscal 2026, alongside a 67.5% reduction in net loss to $3.5 million. The company expanded operations by acquiring Viking Well Service assets and secured its largest government contract worth $19.6 million in Ohio. Looking ahead, Zefiro aims to fully utilize its expanded rig fleet and convert its large contract pipeline into revenue, supported by new state-funded contracts through 2029.

Zefiro Methane's fiscal 2026 results show strong revenue and profit growth alongside reduced net loss. For readers following the energy sector, here is Pluang's market snapshot as of Sep 29, 2026 03:12 WIB: 14 of 38 energy stocks rose while 24 fell. Notable movers include OXY at USD 56.88 with 92% sell orders, WMB at USD 69.24 with 100% buy orders, and TDW at USD 83.21.

More News

Several high-volume stocks plunge sharply amid profit-taking despite positive updates.

Several high-volume stocks plunge sharply amid profit-taking despite positive updates.

Several high-volume stocks including ITG Inc, Adicet Bio, Jaguar Health, Ocular Therapeutix, and Greenland Mines experienced sharp declines despite recent positive company news. The drops, ranging from about 19% to over 32%, appear driven by profit-t...

Market News
Bearish
1 hour ago
Stocks jump on clinical trial updates, acquisition deals, and trading momentum.

Stocks jump on clinical trial updates, acquisition deals, and trading momentum.

Kodiak Sciences surged 178% following positive Phase III trial updates for a wet age-related macular degeneration treatment. Lifecore Biomedical rose 55% after agreeing to a $663.7 million acquisition by Webster Equity Partners. YD Bio gained 22%, li...

Market News
Bullish
1 hour ago
Lifecore Biomedical shares jump 55% on acquisition news, analyst downgrades to Hold.

Lifecore Biomedical shares jump 55% on acquisition news, analyst downgrades to Hold.

Lifecore Biomedical's stock surged 55.24% to $6.52 after announcing an acquisition by Webster Equity Partners offering $6.28 per share in cash plus potential Contingent Value Rights up to $9.67 per share. The deal values the company at up to $663.7 m...

Market News
Bullish
2 hours ago
Espey director sells shares amid stock valued 112% above fair value despite strong earnings.

Espey director sells shares amid stock valued 112% above fair value despite strong earnings.

A director of Espey Manufacturing and Electronics Corp sold 100 shares at $64.49 each, reducing his holdings to 20,550 shares. This insider sale happened after the company reported strong 2026 financial results, including net sales growth to $46.1 mi...

Market News
Neutral
2 hours ago
Vail Resorts beats Q4 revenue estimates, targets $106M in cost savings for profit boost

Vail Resorts beats Q4 revenue estimates, targets $106M in cost savings for profit boost

Vail Resorts reported Q4 earnings per share of -$5.34, slightly better than expected, with revenue of $278.1 million surpassing estimates. The company benefited from a 5.2% rise in mountain revenues, driven by strong pass sales in Australia and stabl...

Company Fundamentals
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App